Awards as PI
| Funding | ||
|---|---|---|
| Early Translational II | Human retinal progenitor cells as candidate therapy for retinitis pigmentosa | $4,738,251 |
| Disease Team Planning | Stem cells for neuroprotection of photoreceptors in retinitis pigmentosa | $37,367 |
| Disease Team Therapy Development - Research | Retinal progenitor cells for treatment of retinitis pigmentosa | $17,306,668 |
Total: $22,082,286.00 |
